Deposition of HA-TiO2 by plasma spray on β-phase Ti-35Nb-7Ta-5Zr alloy for hip stem: Characterization, mechanical properties, corrosion, and in-vitro bioactivity
Abstract
Abstract This research work presents the deposition of titanium oxide (TiO2) reinforced hydroxyapatite (HA) on Ti-35Nb-7Ta-5Zr alloy by plasma spray deposition technique for Hip-stem application. The effect of TiO2 reinforcement (15 and 30 wt%) in HA has been studied on coatings morphology, microstructure, mechanical properties, corrosion resistance, and in-vitro bioactivity was investigated. The microstructure, elemental composition, and phase composition were characterized by FE-SEM, EDS, and XRD. The morphology analysis showed that of HA-coating contains micro-cracks and splats like structure with large globules. The reinforcement of TiO2 in HA improved the microstructure, prevents the formation of micro-cracks, and formed a dense structure. The cross-section morphology shows that HA-15%TiO2 (HA-Tx) and HA-30%TiO2 (HA-Ty) coatings (thickness 185–200 μm) were mechanically bonded with the substrate as compared HA-coatings, that helps in enhancing implant stability. Results also show that microhardness and adhesion strength of HA/TiO2 coatings improved with the reinforcement of TiO2 and HA-30%TiO2 possessed high micro-hardness and adhesion strength (1.35 GPa and 32.5 MPa) in comparison with HA-coating (0.63 GPa and 18.5 MPa). The electron dispersive spectroscopy (EDS) analysis and X-ray diffraction analysis (XRD) results show that HA-TiO2 coatings contain HA and TiO2 phases that prevent the formation of amorphous contents. In contrast, HA-coating contains amorphous content…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.